Literature DB >> 6113548

Relation between central sympathoinhibitory and peripheral pre- and postsynaptic alpha-adrenoceptors as evaluated by different clonidine-like substances in rats.

W Kobinger, L Pichler.   

Abstract

A series of 8 clonidine-like substances were tested in rats on central sympathoinhibition (heart rate decrease in vagotomized rats, D50 = dose which decreased heart rate by 50 beats/min), peripheral postsynaptic activity (blood pressure increase in spinal rats, PD30 = dose which increased blood pressure 30 mm Hg) and peripheral presynaptic activity (inhibition of tachycardia as elicited by electrical stimulation in the spinal canal of pithed rats, ID50 = dose which inhibited for 50%). The D50, PD30 and ID50 were converted in moles/kg and the negative logarithms thereof were correlated. There was a good correlation between the central effect (D50) and both peripheral effects (PD30 and ID50, respectively; r = 0.89 and 0.91, respectively) provided one drug with low lipoid affinity was omitted from calculation (St 600). There was also good correlation between both peripheral effects (PD30 and ID50; r = 0.94) and this could be extended to other imidazolines which are not acting centrally as antihypertensives (oxymetazoline, naphazoline, St 91, tramazoline; r = 0.90). The results were interpreted by (1) the agonistic activity of the clonidine-like drugs mainly at alpha 2-adrenoceptors and (2) the presence of alpha 2-adrenoceptors at peripheral presynaptic, peripheral postsynaptic as well as central cardiovascular sites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6113548     DOI: 10.1007/bf00504226

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8,-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type".

Authors:  W Kobinger; L Pichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

2.  Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptors.

Authors:  G M Drew
Journal:  Eur J Pharmacol       Date:  1976-04       Impact factor: 4.432

3.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Antagonism by mianserin and classical alpha-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine.

Authors:  R D Robson; M J Antonaccio; J K Saelens; J Liebman
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

5.  Investigation into different types of post- and presynaptic alpha-adrenoceptors at cardiovascular sites in rats.

Authors:  W Kobinger; L Pichler
Journal:  Eur J Pharmacol       Date:  1980-08-08       Impact factor: 4.432

6.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.

Authors:  H Schmitt; S Fénard
Journal:  Arzneimittelforschung       Date:  1973-01

7.  Modulating effect of central adrenergic neurones on a vagally mediated cardioinhibitory reflex.

Authors:  W Kobinger; A Walland
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

8.  Lipophilicity and brain disposition of clonidine and structurally related imidazolidines.

Authors:  P B Timmermans; A Brands; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

9.  Relationship between activity and structure in derivatives of clonidine.

Authors:  W Hoefke; W Kobinger; A Walland
Journal:  Arzneimittelforschung       Date:  1975-05

10.  Binding of an imidazolidine (clonidine), an oxazoloazepin (B-HT 933) and a thiazoloazepin (B-HT 920) to rat brain alpha-adrenoceptors and relation to cardiovascular effects.

Authors:  R Hammer; W Kobinger; L Pichler
Journal:  Eur J Pharmacol       Date:  1980-04-04       Impact factor: 4.432

View more
  13 in total

Review 1.  Antihypertensive drugs interacting with alpha- and beta-adrenoceptors. A review of basic pharmacology.

Authors:  P A van Zwieten
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  The cardiovascular effects of MPV 295 [4(5)-2-(2,6-dimethylphenyl)ethylimidazole], a new antihypertensive agent with alpha 2-adrenoceptor agonistic properties.

Authors:  H Ruskoaho; J M Savola; S Kaipiainen; J Puurunen; N Kärki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

3.  Reversal of reserpine-induced ptosis in the mouse by alpha-adrenoceptor-agonists.

Authors:  M J Deniard; J Meignen; F V DeFeudis
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Participation of cardiac presynaptic alpha 2-adrenoceptors in the bradycardiac effects of clonidine and analogues.

Authors:  A de Jonge; P B Timmermans; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

Review 5.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Pharmacological characterization of the alpha adrenoceptors of the dog basilar artery.

Authors:  Y Sakakibara; M Fujiwara; I Muramatsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

7.  B-HT 958, a new alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio.

Authors:  L Pichler; H Hörtnagl; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

8.  Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat.

Authors:  J C Doxey; B Gadie; A C Lane; I F Tulloch
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

9.  Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz.

Authors:  J S Gutkind; M Kazanietz; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

10.  Cardiovascular effects in rats of alpha 1 and alpha 2 adrenergic agents injected into the nucleus tractus solitarii.

Authors:  T Kubo; M Kihara; H Hata; Y Misu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.